Feedback / Questions
CellProtect (ex vivo expanded and activated autologous natural killer cells) - Avaris, XNK Therap
https://www.prnewswire.com/news-releases/xnk-therapeutics-receives-us-orphan-drug-status-for-nk-cell-based-immunotherapy-in-multiple-myeloma-301166343.html
Nov 4, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next